首页>
外国专利>
Compound, oligonucleotide analogue or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of an oligonucleotide analog
Compound, oligonucleotide analogue or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of an oligonucleotide analog
展开▼
机译:化合物,寡核苷酸类似物或其药学上可接受的盐,药物组合物和寡核苷酸类似物的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
"COMPOUND, OLIGONUCLEOTIDE ANALOG OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, AND USE OF AN OLIGONUCLEOTIDE ANALOG". This invention provides novel bicyclonucleoside analogs, which exhibit anti-AIDS activity and intermediates to produce oligonucleotide analogs, which have antisense or antigen activity as well as stability in vivo. The present invention relates to compounds of the following formula (1) or their pharmaceutically acceptable salts. R2 represents a hydrogen atom or a protecting group for a hydroxy group, R2 represents an azido group or an optionally protected amino group or the like, B represents a purin-9-yl group or a group 2 -oxo-1,2-dihydropyrimidin-1-yl, which are optionally substituted by substituents selected from the group 224 below (Group 244) halogen atom, alkyl group having 1-6 carbon atoms, hydroxy, mercapto group, amino group, and the like.
展开▼
机译:“化合物,寡核苷酸类似物或相同的药物可接受的盐,药物组合物以及寡核苷酸类似物的使用”。本发明提供了新颖的双环核苷类似物,其具有抗艾滋病活性,并具有产生寡核苷酸类似物的中间体,该寡核苷酸类似物具有反义或抗原活性以及体内稳定性。本发明涉及下式(1)的化合物或其药学上可接受的盐。 R 2代表氢原子或羟基的保护基,R 2代表叠氮基或任选保护的氨基等,B代表嘌呤-9-基或2-氧-1,2-二氢嘧啶基-1-基,其任选地被选自下面的<224>组(<244>组)的卤原子,具有1-6个碳原子的烷基,羟基,巯基,氨基等的取代基取代。
展开▼